# Vita Vitro

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vita-vitro

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.vitavitro.cn
- Total disclosed funding: $19M
- Latest round: Series C (Sep 7, 2021)
- Investors on record: 8

## About

Based in Shenzhen, China and established in 2015, Vita Vitro is a biotechnology company which focuses on embryo freezing and unfreezing kits technology and provides solutions for assisted reproduction laboratory. The company has completed 6 rounds of funding as of 2021.

The company's main business is research, development, manufacturing, sales and technical support of egg retrieval, frozen culture and embryo transfer related products. The company's self-developed products includes open pulled straw vitrification, VitaVitro 1-step culture medium, VitaVitro gamete buffer medium, VitaVitro flushing buffer medium and VitaVitro fertilization medium.

## Funding rounds

- Series C, Sep 7, 2021, $16M — China International Capital Corporation, Shanghai Zhangjiang Technology Venture Investment Co.,Ltd., Xiangrong Capital
- Series B, Jun 9, 2020 — Dalton Venture, For Future Capital
- Series A, Jan 14, 2019, $3.1M — Redhill Capital
- Series A, Nov 28, 2017 — Toposcend Capital, MED-FINE Capital

## Investors

- Toposcend Capital (https://capitalatlas.ai/funds/toposcend-capital) — Series A
- MED-FINE Capital (https://capitalatlas.ai/funds/med-fine-capital) — Series A
- Redhill Capital (https://capitalatlas.ai/funds/redhill-capital) — Series A
- Dalton Venture (https://capitalatlas.ai/funds/dalton-venture) — Series B
- For Future Capital (https://capitalatlas.ai/funds/for-future-capital) — Series B
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series C
- Shanghai Zhangjiang Technology Venture Investment Co.,Ltd. — Series C
- Xiangrong Capital — Series C